Texas 2009 - 81st Regular

Texas House Bill HB2381

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to disclosure of the prices charged to state agencies in connection with pharmacy benefit manager services.

Impact

If enacted, HB2381 will affect all state agencies in Texas involved in contracting for pharmacy benefit manager services. It specifies that these agencies must provide requested pricing information to other agencies within 30 days, promoting a culture of openness about public expenditures. This disclosure obligation aims to combat unfair pricing practices and provide state agencies with the necessary information to make informed decisions when entering contracts with PBMs.

Summary

House Bill 2381 proposes amendments to Chapter 2158 of the Government Code in Texas, specifically targeting the transparency requirements around pharmacy benefit manager (PBM) services. The primary aim of this legislation is to mandate state agencies to disclose the prices charged by PBMs for their services related to prescription drug programs. This act is intended to enhance transparency in government spending, enabling better oversight of drug pricing and potentially leading to cost savings for state agencies.

Contention

The bill highlights several points of contention, primarily revolving around issues of confidentiality and the potential impact on existing contracts with PBMs. While the bill allows for transparency, it also respects existing contractual obligations that may inhibit full disclosure. Critics of the bill may argue about the potential challenges in balancing the need for transparency with the competitive disadvantages that state agencies might face if sensitive pricing strategies are publicly disclosed. Discussions among stakeholders are likely to revolve around how best to implement these transparency measures without disrupting existing service agreements.

Companion Bills

TX SB704

Identical Relating to the regulation of pharmacy benefit managers and mail order pharmacies.

Previously Filed As

TX HB1754

Relating to the disclosure of certain prescription drug information by a health benefit plan.

TX SB622

Relating to the disclosure of certain prescription drug information by a health benefit plan.

TX HB4990

Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.

TX SB2402

Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.

TX HB3413

Relating to limitations on use of certain pharmacy benefit managers.

TX HB2180

Relating to the application of prescription drug price rebates to reduce health benefit plan enrollee cost sharing.

TX HB4611

Relating to the nonsubstantive revision of the health and human services laws governing the Health and Human Services Commission, Medicaid, and other social services.

TX SB2212

Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

TX HB446

Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.

TX SB332

Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.

Similar Bills

No similar bills found.